Cargando…

Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation

PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaver, M. N., Wintgens, L. I. S., Wijffels, M. C. E. F., Balt, J. C., van Dijk, V. F., Alipour, A., Chaldoupi, S. M., Derksen, R., Boersma, L. V. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925470/
https://www.ncbi.nlm.nih.gov/pubmed/32253598
http://dx.doi.org/10.1007/s10840-020-00728-8
_version_ 1783659274616963072
author Klaver, M. N.
Wintgens, L. I. S.
Wijffels, M. C. E. F.
Balt, J. C.
van Dijk, V. F.
Alipour, A.
Chaldoupi, S. M.
Derksen, R.
Boersma, L. V. A.
author_facet Klaver, M. N.
Wintgens, L. I. S.
Wijffels, M. C. E. F.
Balt, J. C.
van Dijk, V. F.
Alipour, A.
Chaldoupi, S. M.
Derksen, R.
Boersma, L. V. A.
author_sort Klaver, M. N.
collection PubMed
description PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safety. This large registry presents acute success rates and safety outcomes in a daily practice setting. METHODS: A total of 1017 patients undergoing first-time ablation for atrial fibrillation (AF) using PVAC GOLD were included, 644 patients with paroxysmal AF and 373 patients with non-paroxysmal AF, divided into 175 patients receiving PVI only and 198 patients receiving PVI with additional substrate modification. RESULTS: High and comparable percentages of successful PVI could be achieved in all groups (98%, 95% and 99%; p = 0.108). The median total procedure time for all groups was 90 min [70–100]. As expected, the total procedure, ablation and fluoroscopy time were significantly longer in the PVI + substrate modification group compared with the PVI-only cases (all p < 0.001), but not between the PVI-only groups (p = 0.306, p = 0.088, p = 0.233, respectively). A total of 44 complications were observed in 43 patients (4.2%). Major complications were seen in 19 patients (1.87%) and non-major procedure–related complications were seen in 25 patients (2.46%). Complications leaving permanent sequelae were rare and occurred in only four patients (0.39%). Complications did not differ between groups (p = 0.199, p = 0.438, p = 0.240 and p = 0.465 respectively). CONCLUSION: PVAC GOLD performs successful PVI, while reducing procedure times and retaining safety for paroxysmal, persistent and long-standing persistent AF. Safety was unaffected by additional substrate modification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10840-020-00728-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7925470
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79254702021-03-19 Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation Klaver, M. N. Wintgens, L. I. S. Wijffels, M. C. E. F. Balt, J. C. van Dijk, V. F. Alipour, A. Chaldoupi, S. M. Derksen, R. Boersma, L. V. A. J Interv Card Electrophysiol Multimedia Report PURPOSE: The second-generation multi-electrode catheter, pulmonary vein ablation catheter (PVAC) GOLD, was designed to improve the delivery of phased radiofrequency energy and reduce procedure times using a ‘single-shot’ approach for pulmonary vein isolation (PVI), while retaining efficacy and safety. This large registry presents acute success rates and safety outcomes in a daily practice setting. METHODS: A total of 1017 patients undergoing first-time ablation for atrial fibrillation (AF) using PVAC GOLD were included, 644 patients with paroxysmal AF and 373 patients with non-paroxysmal AF, divided into 175 patients receiving PVI only and 198 patients receiving PVI with additional substrate modification. RESULTS: High and comparable percentages of successful PVI could be achieved in all groups (98%, 95% and 99%; p = 0.108). The median total procedure time for all groups was 90 min [70–100]. As expected, the total procedure, ablation and fluoroscopy time were significantly longer in the PVI + substrate modification group compared with the PVI-only cases (all p < 0.001), but not between the PVI-only groups (p = 0.306, p = 0.088, p = 0.233, respectively). A total of 44 complications were observed in 43 patients (4.2%). Major complications were seen in 19 patients (1.87%) and non-major procedure–related complications were seen in 25 patients (2.46%). Complications leaving permanent sequelae were rare and occurred in only four patients (0.39%). Complications did not differ between groups (p = 0.199, p = 0.438, p = 0.240 and p = 0.465 respectively). CONCLUSION: PVAC GOLD performs successful PVI, while reducing procedure times and retaining safety for paroxysmal, persistent and long-standing persistent AF. Safety was unaffected by additional substrate modification. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10840-020-00728-8) contains supplementary material, which is available to authorized users. Springer US 2020-04-06 2021 /pmc/articles/PMC7925470/ /pubmed/32253598 http://dx.doi.org/10.1007/s10840-020-00728-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Multimedia Report
Klaver, M. N.
Wintgens, L. I. S.
Wijffels, M. C. E. F.
Balt, J. C.
van Dijk, V. F.
Alipour, A.
Chaldoupi, S. M.
Derksen, R.
Boersma, L. V. A.
Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title_full Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title_fullStr Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title_full_unstemmed Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title_short Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation
title_sort acute success and safety of the second-generation pvac gold phased rf ablation catheter for atrial fibrillation
topic Multimedia Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925470/
https://www.ncbi.nlm.nih.gov/pubmed/32253598
http://dx.doi.org/10.1007/s10840-020-00728-8
work_keys_str_mv AT klavermn acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT wintgenslis acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT wijffelsmcef acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT baltjc acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT vandijkvf acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT alipoura acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT chaldoupism acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT derksenr acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation
AT boersmalva acutesuccessandsafetyofthesecondgenerationpvacgoldphasedrfablationcatheterforatrialfibrillation